Skip to content
Annika Bansal – Lifestyle
Author:
B. Braun Medical Inc.
B. Braun Announces Approval and Commercialization of First Generic Sugammadex Injection in the U.S. Market
July 14, 2026
B. Braun Launches Rocuronium Bromide Injection in a Room-Temperature-Stable Prefilled Syringe
May 4, 2026
B. Braun Announces Significant Reduction of Greenhouse Gas Emissions through Renewable Electricity Purchase Agreements
March 6, 2026